It states that SMBG should not be routinely offered to adults with T2DM unless they meet any of the following criteria: (1) the patient is on insulin; (2) there is evidence of hypoglycaemic episodes; (3) the patient is pregnant or is planning to become pregnant; (4) the patient is on oral medication that increases their risk of hypoglycaemic episodes and drives large vehicles or operates heavy machinery. Here, INS is linked to type 2 diabetes mellitus.